| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/2003 | EP1282444A1 Antithrombotic agents |
| 02/12/2003 | EP1282443A1 Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 02/12/2003 | EP1282442A1 Cancer treatments by using a combination of an antibody against her2 and interleukin-2 |
| 02/12/2003 | EP1282439A1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR |
| 02/12/2003 | EP1282438A1 Pharmaceutical composition comprising a factor viia and a factor xiii |
| 02/12/2003 | EP1282437A2 Method for treating cartilage disorders |
| 02/12/2003 | EP1282436A2 Treatment of acute coronary syndrome with glp-1 |
| 02/12/2003 | EP1282435A2 Interleukin-1 inhibitors in the treatment of diseases |
| 02/12/2003 | EP1282434A1 Method for cell adhesion and wound healing |
| 02/12/2003 | EP1282433A1 Transgenically produced decorin |
| 02/12/2003 | EP1282432A1 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282425A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP1282411A1 Method of treating cancer |
| 02/12/2003 | EP1282409A1 Insulin formulation for inhalation |
| 02/12/2003 | EP1282403A1 Non-invasive gene targeting to the brain |
| 02/12/2003 | EP1282400A2 Pharmaceutical form of administration for peptides, methods for its production and use |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1135169B1 Use of a pharmaceutical composition comprising an anti-cancer agent and at least a peptide |
| 02/12/2003 | EP1094833B1 Oxidized thymosin beta 4 |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | EP1003542B1 Use of substances having oxytocin activity for preparation of medicaments for wound healing |
| 02/12/2003 | EP0969877B1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 02/12/2003 | EP0966299B1 Novel oral formulations of calcitonin |
| 02/12/2003 | EP0941112B1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors |
| 02/12/2003 | EP0934073B1 Pharmaceutical composition, comprising complement proteins, for the treatment of helicobacter infections and a method for the preparation of the composition |
| 02/12/2003 | EP0871456B1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
| 02/12/2003 | EP0865447B1 Cyclic dodecapeptide and process for the preparation thereof |
| 02/12/2003 | EP0862456A4 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | EP0637246B1 Use of modified c-reactive protein for the preparation of a medicament for the treatment of cancer |
| 02/12/2003 | CN1397019A Screening method |
| 02/12/2003 | CN1396929A Cyclic compound |
| 02/12/2003 | CN1396928A Process for preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides |
| 02/12/2003 | CN1396927A Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396906A Calcilytic compounds |
| 02/12/2003 | CN1396832A Pre-transplant accommodated organs resistant to anti-donor immunity |
| 02/12/2003 | CN1396825A Composition, kit for benefitting cardiovasaclaire and method |
| 02/12/2003 | CN1396178A Engineered polypeptide resisting infection of coated virus (hepatitis B virus) and its preparing process |
| 02/12/2003 | CN1396176A Method for purifying drug active protein by cation exchange chromatogrphy |
| 02/12/2003 | CN1395967A Grassland locoism toxin vaccine |
| 02/12/2003 | CN1101472C Process for preparing recombination colbacillus periplams protein liquid |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101224C Injection for giving up addiction |
| 02/11/2003 | US6518417 Antisense nucleic acids targeting HBV |
| 02/11/2003 | US6518413 Isolated nucleic acid encoding the polypeptide which, on expression in a host cell, produces the polypeptide; use in treatment of muscular dystrophy |
| 02/11/2003 | US6518412 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 02/11/2003 | US6518406 Adding a saccharide and citrate to a solution of antithrombin-III to precipitate the impurities; used in the prophylaxis and treatment of thromboembolic disorders |
| 02/11/2003 | US6518405 Binding compound comprised of antibody binding site binding primate proteins BS10.55 or YTF03, or nucleic acids coding for, or fusion protein of both; kit for qualitative or quantitative analysis of enzymatic activity; immunoassay |
| 02/11/2003 | US6518404 Human endothelin-bombesin receptor antibodies |
| 02/11/2003 | US6518403 Antibodies that bind an adipocyte-specific protein homolog |
| 02/11/2003 | US6518402 Antibodies to c5 polypeptides |
| 02/11/2003 | US6518399 Isolation of novel GABAb-R2 receptor protein subtype; Gamma-amino-butyric acid (GABA); human neurotransmitter; amino acid and nucleotide sequences |
| 02/11/2003 | US6518397 Pharmaceuticals for modulating hormone responsiveness |
| 02/11/2003 | US6518311 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 02/11/2003 | US6518278 Administering a synergistically effective amount of irinotecane and subsequently with a synergistically effective amount of cis-oxalato (1R,2R-diaminocyclohexane) Pt (II) |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518256 Compounds and methods for therapy and diagnosis of lung cancer |
| 02/11/2003 | US6518255 Administering, via multiple applications to target tissue, a dose of an adenoviral vector comprising a DNA encoding an angiogenic peptide which is an endothelial growth factor and a carrier to increase level of perfusion of blood to target |
| 02/11/2003 | US6518246 Pharmaceutical composition and method for the treatment of neoplastic cells |
| 02/11/2003 | US6518245 Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase |
| 02/11/2003 | US6518244 Cardiovascular disorders |
| 02/11/2003 | US6518243 Desleucyl glycopeptide antibiotics and methods of making same |
| 02/11/2003 | US6518242 Derivatives of glycopeptide antibacterial agents |
| 02/11/2003 | US6518241 Shock heat treatment of polypeptides |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518238 Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
| 02/11/2003 | US6518237 Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 02/11/2003 | US6518236 FGF homologs |
| 02/11/2003 | US6518235 Methods for improving brain function using leptin or analogs thereof |
| 02/11/2003 | US6518063 Osf2/Cbfa1 nucleic acids and methods of use therefor |
| 02/11/2003 | US6518062 Enzyme combinations for destroying proliferative cells |
| 02/11/2003 | US6518061 Interleukin-13 (IL-13); Delivery of a modified Pseudomonas exotoxin (effector molecule), attached to an interleukin, to tumor cells bearing interleukin receptors; antitumor agent |
| 02/11/2003 | US6518055 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/11/2003 | US6518052 Human homologue of yeast helicase and uses thereof |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6518045 Feline cytokine protein |
| 02/11/2003 | US6518043 Proteins suppressing proliferation of lympho-hematopoietic cells |
| 02/11/2003 | US6518041 An isolated non-protein-encoding nucleic acid sequence functioning as a hormone response element which binds an androgen- or a progesterone- regulated receptor, comprising: a DNA sequence of the formula (SEQ ID NO:6) (N)x TCTCATTCTGTTCC, |
| 02/11/2003 | US6518028 Methods for the early diagnosis of ovarian and prostate cancer |
| 02/11/2003 | US6518015 Peptide comprising the sequence CAFRQVC and methods using it |
| 02/11/2003 | US6518013 Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission |
| 02/11/2003 | US6518010 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 02/11/2003 | US6517858 Bioactive prostheses with immunosuppressive, antistenotic and antithrombotic properties |
| 02/11/2003 | US6517848 Method for sequestration of skin irritants with absorbent article composition |
| 02/11/2003 | US6517842 Marburg virus vaccines |
| 02/11/2003 | US6517837 Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer |
| 02/11/2003 | US6517836 Aziridin-1-yl nitrobenzamides as prodrugs in conjunction with nitroreductase enzymes |
| 02/11/2003 | US6517833 Vision defects |
| 02/11/2003 | US6517828 C-CAM as an angiogenesis inhibitor |
| 02/11/2003 | US6517827 Anionic polymers as toxin binders and antibacterial agent |
| 02/11/2003 | US6517826 Anionic polymers as toxin binders and antibacterial agents |
| 02/11/2003 | US6517203 System, apparatus, and method for correcting vision using electro-active spectacles |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2170509C Dna encoding prostaglandin receptor ep2 |
| 02/11/2003 | CA2162880C Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv |
| 02/11/2003 | CA2151564C Monomeric insulin analog formulations |
| 02/11/2003 | CA2142181C Androgen regulation with dna sequences of rat probasin gene |